These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32212852)

  • 1. Everolimus Rescues the Phenotype of Elastin Insufficiency in Patient Induced Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells.
    Kinnear C; Agrawal R; Loo C; Pahnke A; Rodrigues DC; Thompson T; Akinrinade O; Ahadian S; Keeley F; Radisic M; Mital S; Ellis J
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1325-1339. PubMed ID: 32212852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling and rescue of the vascular phenotype of Williams-Beuren syndrome in patient induced pluripotent stem cells.
    Kinnear C; Chang WY; Khattak S; Hinek A; Thompson T; de Carvalho Rodrigues D; Kennedy K; Mahmut N; Pasceri P; Stanford WL; Ellis J; Mital S
    Stem Cells Transl Med; 2013 Jan; 2(1):2-15. PubMed ID: 23283491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR (Mechanistic Target of Rapamycin) Inhibition Decreases Mechanosignaling, Collagen Accumulation, and Stiffening of the Thoracic Aorta in Elastin-Deficient Mice.
    Jiao Y; Li G; Li Q; Ali R; Qin L; Li W; Qyang Y; Greif DM; Geirsson A; Humphrey JD; Tellides G
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1657-1666. PubMed ID: 28751568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin inhibits smooth muscle cell proliferation and obstructive arteriopathy attributable to elastin deficiency.
    Li W; Li Q; Qin L; Ali R; Qyang Y; Tassabehji M; Pober BR; Sessa WC; Giordano FJ; Tellides G
    Arterioscler Thromb Vasc Biol; 2013 May; 33(5):1028-35. PubMed ID: 23493289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient Circumferential Growth Is the Primary Determinant of Aortic Obstruction Attributable to Partial Elastin Deficiency.
    Jiao Y; Li G; Korneva A; Caulk AW; Qin L; Bersi MR; Li Q; Li W; Mecham RP; Humphrey JD; Tellides G
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):930-941. PubMed ID: 28254817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connection between elastin haploinsufficiency and increased cell proliferation in patients with supravalvular aortic stenosis and Williams-Beuren syndrome.
    Urbán Z; Riazi S; Seidl TL; Katahira J; Smoot LB; Chitayat D; Boyd CD; Hinek A
    Am J Hum Genet; 2002 Jul; 71(1):30-44. PubMed ID: 12016585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Smooth Muscle β-Catenin Hinders Neointima Formation After Vascular Injury.
    Riascos-Bernal DF; Chinnasamy P; Gross JN; Almonte V; Egaña-Gorroño L; Parikh D; Jayakumar S; Guo L; Sibinga NES
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):879-888. PubMed ID: 28302627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De Novo Elastin Assembly Alleviates Development of Supravalvular Aortic Stenosis-Brief Report.
    Ellis MW; Riaz M; Huang Y; Anderson CW; Hoareau M; Li X; Luo H; Lee S; Park J; Luo J; Batty LD; Huang Q; Lopez CA; Reinhardt DP; Tellides G; Qyang Y
    Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1674-1682. PubMed ID: 38752350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of microRNA-145 in human embryonic stem cell differentiation into vascular cells.
    Yamaguchi S; Yamahara K; Homma K; Suzuki S; Fujii S; Morizane R; Monkawa T; Matsuzaki Y; Kangawa K; Itoh H
    Atherosclerosis; 2011 Dec; 219(2):468-74. PubMed ID: 21945499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thoracic aortic disease in tuberous sclerosis complex: molecular pathogenesis and potential therapies in Tsc2+/- mice.
    Cao J; Gong L; Guo DC; Mietzsch U; Kuang SQ; Kwartler CS; Safi H; Estrera A; Gambello MJ; Milewicz DM
    Hum Mol Genet; 2010 May; 19(10):1908-20. PubMed ID: 20159776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates.
    Bajpai VK; Mistriotis P; Loh YH; Daley GQ; Andreadis ST
    Cardiovasc Res; 2012 Dec; 96(3):391-400. PubMed ID: 22941255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin β3 inhibition is a therapeutic strategy for supravalvular aortic stenosis.
    Misra A; Sheikh AQ; Kumar A; Luo J; Zhang J; Hinton RB; Smoot L; Kaplan P; Urban Z; Qyang Y; Tellides G; Greif DM
    J Exp Med; 2016 Mar; 213(3):451-63. PubMed ID: 26858344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking potassium channels: a new principle for treating restenosis?
    Olschewski A
    Cardiovasc Res; 2011 Feb; 89(2):255-7. PubMed ID: 21156820
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of iPSC-Derived Smooth Muscle Cells to Model Physiology and Pathology.
    Kwartler CS; Esparza Pinelo JE
    Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1523-1536. PubMed ID: 38695171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous Cellular Contributions to Elastic Laminae Formation in Arterial Wall Development.
    Lin CJ; Staiculescu MC; Hawes JZ; Cocciolone AJ; Hunkins BM; Roth RA; Lin CY; Mecham RP; Wagenseil JE
    Circ Res; 2019 Nov; 125(11):1006-1018. PubMed ID: 31590613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients.
    Sun L; Bai Y; Zhao R; Sun T; Cao R; Wang F; He G; Zhang W; Chen Y; Ye P; Du G
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1386-97. PubMed ID: 27199451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells.
    Ge X; Ren Y; Bartulos O; Lee MY; Yue Z; Kim KY; Li W; Amos PJ; Bozkulak EC; Iyer A; Zheng W; Zhao H; Martin KA; Kotton DN; Tellides G; Park IH; Yue L; Qyang Y
    Circulation; 2012 Oct; 126(14):1695-704. PubMed ID: 22914687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cadherin promotes vascular smooth muscle cell dedifferentiation via a GSK3β-inactivation dependent mechanism.
    Frismantiene A; Dasen B; Pfaff D; Erne P; Resink TJ; Philippova M
    Cell Signal; 2016 May; 28(5):516-530. PubMed ID: 26907733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment with PDGF-BB and endothelin-1 synergistically induces vascular hyperplasia and loss of contractility in organ-cultured rat tail artery.
    Kida T; Chuma H; Murata T; Yamawaki H; Matsumoto S; Hori M; Ozaki H
    Atherosclerosis; 2011 Feb; 214(2):288-94. PubMed ID: 21129745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-1 induces pulmonary but not aortic smooth muscle cell migration by activating ERK1/2 MAP kinase.
    Meoli DF; White RJ
    Can J Physiol Pharmacol; 2010 Aug; 88(8):830-9. PubMed ID: 20725141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.